Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Clavijo PE"'
Autor:
Morgan EL; Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Communication Disorders, National Institutes of Health, Bethesda, Maryland.; School of Life Sciences, University of Sussex, Brighton, United Kingdom., Saleh AD; Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Communication Disorders, National Institutes of Health, Bethesda, Maryland., Cornelius S; Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Communication Disorders, National Institutes of Health, Bethesda, Maryland., Carlson SG; Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Communication Disorders, National Institutes of Health, Bethesda, Maryland., Toni T; Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Communication Disorders, National Institutes of Health, Bethesda, Maryland., Cheng H; Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Communication Disorders, National Institutes of Health, Bethesda, Maryland., Jeon J; Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Communication Disorders, National Institutes of Health, Bethesda, Maryland., Viswanathan R; Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Communication Disorders, National Institutes of Health, Bethesda, Maryland., Yang X; Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Communication Disorders, National Institutes of Health, Bethesda, Maryland., Silvin C; Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Communication Disorders, National Institutes of Health, Bethesda, Maryland., Clavijo PE; Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Communication Disorders, National Institutes of Health, Bethesda, Maryland., Sowers AL; Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Mitchell JB; Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Ormanoglu P; RNAi Screening Facility, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., Lal Nag M; RNAi Screening Facility, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., Martin SE; RNAi Screening Facility, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., Chen Z; Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Communication Disorders, National Institutes of Health, Bethesda, Maryland., Van Waes C; Tumor Biology Section, Head and Neck Surgery Branch, National Institute on Deafness and Communication Disorders, National Institutes of Health, Bethesda, Maryland.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Nov 01; Vol. 4 (11), pp. 2903-2918.
Autor:
Fay M; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Clavijo PE; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Allen CT; Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Publikováno v:
Head & neck [Head Neck] 2024 Oct; Vol. 46 (10), pp. 2591-2599. Date of Electronic Publication: 2024 Apr 15.
Autor:
Bai K; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, U.S.A., Clavijo PE; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, U.S.A., Robbins Y; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, U.S.A., Norberg SM; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, U.S.A., Allen CT; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, U.S.A.; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, U.S.A.
Publikováno v:
The Laryngoscope [Laryngoscope] 2024 Jul; Vol. 134 (7), pp. 3238-3244. Date of Electronic Publication: 2024 Mar 04.
Autor:
Sakakibara N; Office of Biotechnology Products, Center for Drug Evaluation and Research, FDA, Silver Spring, MD, United States., Clavijo PE; Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, MD, United States., Sievers C; Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, MD, United States., Gray VC; Office of Biotechnology Products, Center for Drug Evaluation and Research, FDA, Silver Spring, MD, United States., King KE; Office of Biotechnology Products, Center for Drug Evaluation and Research, FDA, Silver Spring, MD, United States., George AL; Office of Biotechnology Products, Center for Drug Evaluation and Research, FDA, Silver Spring, MD, United States., Ponnamperuma RM; Office of Biotechnology Products, Center for Drug Evaluation and Research, FDA, Silver Spring, MD, United States., Walter BA; Genitourinary Malignancies Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, MD, United States., Chen Z; Head and Neck Surgery Branch, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, MD, United States., Van Waes C; Head and Neck Surgery Branch, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, MD, United States., Allen CT; Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, NIH, Bethesda, MD, United States., Weinberg WC; Office of Biotechnology Products, Center for Drug Evaluation and Research, FDA, Silver Spring, MD, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Aug 10; Vol. 14, pp. 1200970. Date of Electronic Publication: 2023 Aug 10 (Print Publication: 2023).
Autor:
Sievers C; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA., Robbins Y; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA., Bai K; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA., Yang X; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA., Clavijo PE; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA., Friedman J; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA., Sinkoe A; Genitourinary Malignancies Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA., Norberg SM; Genitourinary Malignancies Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA., Hinrichs C; Rutgers Cancer Center, New Brunswick, NJ, USA., Van Waes C; Tumor Biology Section, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA., Allen CT; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA. clint.allen@nih.gov.
Publikováno v:
Communications biology [Commun Biol] 2021 Dec 20; Vol. 4 (1), pp. 1416. Date of Electronic Publication: 2021 Dec 20.
Autor:
Valencia JC; Laboratory of Cancer Immunometabolism, CCR, NCI, Frederick Maryland. valencij@mail.nih.gov., Erwin-Cohen RA; Laboratory of Cancer Immunometabolism, CCR, NCI, Frederick Maryland., Clavijo PE; Head and Neck Surgery Branch, National Institute on Deafness and other Communication Disorders, Bethesda, Maryland., Allen C; Head and Neck Surgery Branch, National Institute on Deafness and other Communication Disorders, Bethesda, Maryland., Sanford ME; Laboratory of Cancer Immunometabolism, CCR, NCI, Frederick Maryland., Day CP; Laboratory of Cancer Biology and Genetics, CCR, NCI, Bethesda, Maryland., Hess MM; Laboratory of Cancer Immunometabolism, CCR, NCI, Frederick Maryland., Johnson M; Laboratory of Cancer Immunometabolism, CCR, NCI, Frederick Maryland., Yin J; Laboratory of Cancer Immunometabolism, CCR, NCI, Frederick Maryland., Fenimore JM; Laboratory of Cancer Immunometabolism, CCR, NCI, Frederick Maryland., Bettencourt IA; Laboratory of Cancer Immunometabolism, CCR, NCI, Frederick Maryland., Tsuneyama K; Tokushima University Graduate School, Tokushima, Japan., Romero ME; CVPath Institute, Gaithersburg, Maryland., Klarmann KD; Laboratory of Cancer Immunometabolism, CCR, NCI, Frederick Maryland., Jiang P; Cancer Data Science laboratory, CCR, NCI, Bethesda, Maryland., Bae HR; Laboratory of Cancer Immunometabolism, CCR, NCI, Frederick Maryland., McVicar DW; Laboratory of Cancer Immunometabolism, CCR, NCI, Frederick Maryland., Merlino G; Laboratory of Cancer Biology and Genetics, CCR, NCI, Bethesda, Maryland., Edmondson EF; Molecular Histopathology Laboratory, NCI, Frederick, Maryland., Anandasabapathy N; Weill Cornell Medicine, New York, New York., Young HA; Laboratory of Cancer Immunometabolism, CCR, NCI, Frederick Maryland.
Publikováno v:
Cancer research [Cancer Res] 2021 Dec 01; Vol. 81 (23), pp. 5977-5990. Date of Electronic Publication: 2021 Oct 12.
Autor:
Robbins Y; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA., Friedman J; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA., Clavijo PE; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA., Sievers C; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA., Bai K; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA., Donahue RN; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Schlom J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Sinkoe A; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Hinrichs CS; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Allen C; Section on Translational Tumor Immunology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, USA clint.allen@nih.gov., Abdul Sater H; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Gulley JL; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA., Norberg S; Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Aug; Vol. 9 (8).
Autor:
Auquilla-Clavijo PE; Hospital Universitario Miguel Servet - Cardiologia, Zaragoza - Espanha., Calvo-Galiano N; Hospital Universitario Miguel Servet - Cardiologia, Zaragoza - Espanha., Povar-Echeverría M; Hospital Universitario Miguel Servet -Medicina Interna, Zaragoza - Espanha., Oloriz-Sanjuan T; Hospital Universitario Miguel Servet - Cardiologia, Zaragoza - Espanha., Diaz-Cortejana F; Hospital Universitario Miguel Servet - Cardiologia, Zaragoza - Espanha., Asso-Abadia A; Hospital Universitario Miguel Servet - Cardiologia, Zaragoza - Espanha.
Publikováno v:
Arquivos brasileiros de cardiologia [Arq Bras Cardiol] 2021 Jun; Vol. 116 (6), pp. 1139-1148.
Autor:
Lee MY; NIDCD, National Institutes of Health, Bethesda, Maryland, USA.; Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, USA., Robbins Y; NIDCD, National Institutes of Health, Bethesda, Maryland, USA., Sievers C; NIDCD, National Institutes of Health, Bethesda, Maryland, USA., Friedman J; NIDCD, National Institutes of Health, Bethesda, Maryland, USA., Abdul Sater H; Genitourinary Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Clavijo PE; NIDCD, National Institutes of Health, Bethesda, Maryland, USA., Judd N; Mid-Atlantic Permanente Medical Group, Rockville, Maryland, USA., Tsong E; Mid-Atlantic Permanente Medical Group, Rockville, Maryland, USA., Silvin C; NIDCD, National Institutes of Health, Bethesda, Maryland, USA., Soon-Shiong P; NantKwest, Culver City, California, USA., Padget MR; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Schlom J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Hodge J; Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USA., Hinrichs C; Genitourinary Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Allen C; NIDCD, National Institutes of Health, Bethesda, Maryland, USA clint.allen@nih.gov.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Mar; Vol. 9 (3).
Autor:
Povar-Echeverría M; Servicio de Medicina Interna, Hospital Universitario Miguel Servet, 50009 Zaragoza, Spain., Auquilla-Clavijo PE; Servicio de Cardiología, Hospital Royo Villanova, 50015 Zaragoza, Spain., Andrès E; Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France., Martin-Sánchez FJ; Servicio de Medicina Interna, Facultad de Medicina, Instituto de Investigación Sanitaria del Hospital San Carlos, Hospital Clínico San Carlos, Universidad Complutense de Madrid, 28040 Madrid, Spain., Laguna-Calle MV; Servicio de Medicina Interna, Facultad de Medicina, Instituto de Investigación Sanitaria del Hospital San Carlos, Hospital Clínico San Carlos, Universidad Complutense de Madrid, 28040 Madrid, Spain., Calvo-Elías AE; Servicio de Medicina Interna, Facultad de Medicina, Instituto de Investigación Sanitaria del Hospital San Carlos, Hospital Clínico San Carlos, Universidad Complutense de Madrid, 28040 Madrid, Spain., Lorenzo-Villalba N; Service de Médecine Interne, Diabète et Maladies Métaboliques, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France., Méndez-Bailón M; Servicio de Medicina Interna, Facultad de Medicina, Instituto de Investigación Sanitaria del Hospital San Carlos, Hospital Clínico San Carlos, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2021 Feb 01; Vol. 10 (3). Date of Electronic Publication: 2021 Feb 01.